Organism name | Amorpha fruticosa |
---|---|
Genus | Amorpha |
Family | Fabaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Amorpha fruticosa |
---|---|
Linked NCBI taxonomy ID | 48131 |
Linked level | species |
Family in NCBI taxonomy | Fabaceae |
---|---|
ID | 3803 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00004139
![]() |
Salipurpin
/ Apigenin 5-glucoside / Apigenin 5-O-beta-D-glucopyranoside |
No. 2 | No. 15 |
![]() |
||||
C00002525
![]() |
Formononetin
/ 7-Hydroxy-4'-methoxyisoflavone |
CHEMBL242341
|
C007768
|
24 / 36 / 58 | 13 / 0 | No. 3 | No. 15 |
![]() |
C00009417
![]() |
7,2',4',5'-Tetramethoxyisoflavone
|
CHEMBL478578
|
C091093
|
No. 8 | No. 15 |
![]() |
||
C00008321
![]() |
Amoradicin
|
No. 19 | No. 14 |
![]() |
||||
C00008176
![]() |
5,7-Dihydroxy-8-C-geranylflavanone
|
No. 19 | No. 14 |
![]() |
||||
C00008322
![]() |
Amoradinin
|
No. 19 | No. 14 |
![]() |
||||
C00009601
![]() |
Dehydrodeguelin
/ 6a,12a-Dehydrodeguelin |
CHEMBL465673
|
No. 24 | No. 15 |
![]() |
|||
C00009605
![]() |
Dehydrotoxicarol
/ 7a,13a-Didehydrotoxicarol |
CHEMBL122787
|
No. 24 | No. 15 |
![]() |
|||
C00009986
![]() |
6-Hydroxy-6a,12a-dehydro-alpha-toxicarol
|
No. 24 | No. 15 |
![]() |
||||
C00009413
![]() |
7-Hydroxy-2',4',5'-trimethoxyisoflavone
|
CHEMBL455048
|
No. 35 | No. 15 |
![]() |
|||
C00008325
![]() |
Amorinin
|
No. 39 |
![]() |
|||||
C00008473
![]() |
Amorin
|
No. 39 |
![]() |
|||||
C00008475
![]() |
Amoridin
|
No. 39 |
![]() |
|||||
C00008476
![]() |
Amoricin
|
No. 39 |
![]() |
|||||
C00044194
![]() |
Isoamorin
|
No. 39 |
![]() |
|||||
C00008324
![]() |
Amoritin
|
No. 170 | No. 14 |
![]() |
||||
C00014178
![]() |
Isoamoritin
/ 5,7,3'-Trihydroxy-4'-methoxy-6,8,5'-triprenylflavanone |
No. 170 | No. 14 |
![]() |
||||
C00008269
![]() |
Amorilin
|
CHEMBL561642
|
No. 170 | No. 14 |
![]() |
|||
C00008323
![]() |
Amorisin
|
CHEMBL551156
|
No. 170 | No. 14 |
![]() |
|||
C00009604
![]() |
Dehydroamorphigenin
/ 6a,12a-Didehydroamorphigenin |
CHEMBL1456805
CHEMBL1613441 |
4 / 7 / 11 | No. 236 | No. 15 |
![]() |
||
C00009974
![]() |
3-O-Demethylamorphigenin
|
No. 281 | No. 15 |
![]() |
||||
C00009590
![]() |
Dalbinol
|
CHEMBL465761
|
No. 281 | No. 15 |
![]() |
|||
C00044049
![]() |
12a-Hydroxyamorphigenin
|
CHEMBL515078
|
C044989
|
No. 281 | No. 15 |
![]() |
||
C00009576
![]() |
Dihydroamorphigenin
/ 22,23-Dihydro-24-hydroxyrotenone |
No. 281 | No. 15 |
![]() |
||||
C00009575
![]() |
Amorphigenin
/ 8'-Hydroxyrotenone |
CHEMBL465552
CHEMBL1447847 CHEMBL1490209 |
C049148
|
7 / 8 / 12 | 1 / 0 | No. 281 | No. 15 |
![]() |
C00009577
![]() |
Dalpanol
/ 6',7'-Dihydro-6'-hydroxyrotenone |
CHEMBL518129
CHEMBL1700300 |
3 / 3 / 1 | No. 281 | No. 15 |
![]() |
||
C00002537
![]() |
Rotenolone
/ 12a-Hydroxyrotenone |
CHEMBL240545
|
No. 281 | No. 15 |
![]() |
|||
C00009579
![]() |
Amorphigenol
|
No. 281 | No. 15 |
![]() |
||||
C00020130
![]() |
gamma-Muurolene
/ 1beta-Cadina-4,10(15)-diene |
No. 283 | No. 39 |
![]() |
||||
C00011617
![]() |
AR-Curcumene
/ (R)-(-)-alpha-Curcumene |
CHEMBL469717
|
No. 456 | No. 38 |
![]() |
|||
C00009744
![]() |
Amorphaquinone
/ 7-Hydroxy-8,3',4'-trimethoxyisoflavanquinone |
No. 517 |
![]() |
|||||
C00009591
![]() |
11-Hydroxytephrosin
|
CHEMBL419669
|
No. 589 | No. 15 |
![]() |
|||
C00002578
![]() |
Tephrosin
|
CHEMBL241806
|
C480848
|
6 / 0 | No. 589 | No. 15 |
![]() |
|
C00009574
![]() |
Rotenonic acid
|
CHEMBL2181295
|
No. 765 |
![]() |
||||
C00010180
![]() |
Amorphol
/ Amorphigenol O-vicianoside |
No. 813 |
![]() |
|||||
C00010181
![]() |
Dalbin
/ Dalbinol O-glucoside |
No. 813 |
![]() |
|||||
C00015333
![]() |
Amorphastilbol
/ 3,5-Dihydroxy-4-geranylstilbene |
CHEMBL500257
|
3 / 5 / 3 | No. 1111 | No. 13 |
![]() |
||
C00015437
![]() |
Amorfrutin A
/ 3-Hydroxy-4-isopentenyl-5-methoxybibenzyl-2-carboxylic acid |
CHEMBL491820
|
9 / 14 / 6 | No. 1953 |
![]() |
|||
C00015520
![]() |
Amorfrutin B
/ 3-Hydroxy-5-methoxy-4-geranylbibenzyl-2-carboxylic acid |
No. 1953 |
![]() |
|||||
C00013562
![]() |
Amorphispironone
/ (1R,7'aR,10'aS)-10',10'a-Dihydro-4,5-dimethoxy-3',3'-dimethylspiro[3,5-cyclohexadiene-1,8'-[3H,8H]furo[3,4-e']benzo[1,2-b:3,4-b']dipyran]-2,7'(7'aH)-dione |
CHEMBL491001
CHEMBL1712104 CHEMBL1985734 |
6 / 8 / 4 | No. 7246 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002525 C00009577 C00013562 C00015437 | 0 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00002525 C00015333 C00015437 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00002525 C00009575 C00009604 | 2 / 5 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002525 C00015333 C00015437 | 5 / 3 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002525 C00009575 C00009604 | 1 / 2 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002525 C00009575 C00009604 | 4 / 3 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00002525 C00015333 C00015437 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002525 C00009575 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002525 C00009575 | 1 / 1 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00013562 C00015437 | 7 / 3 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002525 C00009604 | 0 / 1 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002525 C00009575 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00009577 C00015437 | 2 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002525 | 1 / 0 |
O75496 | Geminin | Unclassified protein | C00015437 | 0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002525 | 4 / 2 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00015437 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00015437 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002525 | 0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00002525 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00009575 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002525 | 3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002525 | 2 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00013562 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00013562 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00013562 | 1 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00013562 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002525 | 4 / 1 |
P31639 | Sodium/glucose cotransporter 2 | Glucose | C00002525 | 1 / 1 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002525 | 7 / 37 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002525 | 0 / 0 |
P13866 | Sodium/glucose cotransporter 1 | Glucose | C00002525 | 1 / 1 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00002525 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002525 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00009577 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00002525
C00009575
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002525
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002525
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00002525
|
2056 | EPO, EP, MVCD2 | erythropoietin |
C00002525
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00002525
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00002525
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00002525
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00002525
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00002525
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002525
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002525
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002525
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00002578
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00002578
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00002578
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00002578
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002578
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002578
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#114500 | Colorectal cancer; crc |
P84022
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#133239 | Esophageal cancer |
P04637
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#606824 | Glucose/galactose malabsorption; ggm |
P13866
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P04637
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#601665 | Obesity |
P37231
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#233100 | Renal glucosuria; glys1 |
P31639
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01261 | Congenital glucose-galactose malabsorption (GGM) |
P13866
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H01126 | Familial renal glucosuria (FRG) |
P31639
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|